| |
PPHF 2012 Viral Hepatitis Early Identification and Linkage to Care FOA - May 17, 2012
|
| |
| |
Agency: Centers for Disease Control and Prevention
Program Description:
Put downloadable attachment here
Download the PDf here
PPHF Program: PPHF 2012 Viral Hepatitis
Title: PPHF12: Early Identification and Linkage to Care for Persons with Chronic HBV and HCV Infections - financed solely be 2012 Prevention and Public Health Funds
Mechanism/Procurement Type: FOA
Date Released: May 17, 2012
Description: The purpose of this FOA is to support the implementation of a viral hepatitis testing initiative to increase early identification of persons with HBV and HCV infections, with a focus on populations that are disproportionately a ffected by these infections, and to enhance linkage to care, treatment, and preventive services for persons with these infections.
Agency Contact:
Alycia Downs
ADowns@cdc.gov
404-718-8509
Part I: The title of this Funding Opportunity Announcement is revised to
"PPHF 2012 Viral Hepatitis, Early Identification and Linkage to Care for Person with Chronic HBV and HCV Infections Financed Solely by 2012 Prevention and Public Health Funds".
Estimated Total Program Funding: $6,500,000
Award Ceiling: $1,500,000
Award Floor: $300,000
PPHF 2012 Viral Hepatitis, Early Identification, and Linkage to Care for Persons with Chronic HBV and HCV Infections Financed Solely by 2012 Prevention and Public Health Fund
http://www.grants.gov/search/search.do;jsessionid=K1qDP7dZ11k91PQwnCPJ29K7spLVLJKjflxbpkW98k7fBxcWrT2x!-1021879135?oppId=171575&mode=VIEW
This funding opportunity announcement (FOA) reflects Centers for Disease Control and Prevention (CDC) efforts to improve early identification of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in clinical and community settings and to enhance linkage to care, treatment, and preventive services for infected persons. To meet this prevention goal, the FOA includes two (2) categories: Category A - Early Identification and Linkage to Care for Foreign-born Persons with Hepatitis B; and Category B - Testing for HCV Infection and Enhancing Linkage to Care for Persons with Hepatitis C.
Letter of Intent Deadline Date: June 8, 2012
Application Deadline Date: July 2, 2012, 5:00 p.m. U.S. Eastern Standard Time
Additional Key Dates: Potential applicants may participate in a webinar regarding this Funding Opportunity Announcement (FOA). The webinar will be conducted by the Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and Tuberculosis Prevention, on
May 30, 2012 from 3:00 p.m. - 4:00 p.m. Eastern Daylight Savings Time. Registration is required for this webinar. More information can be found at Section VIII. Other Information.
CDC announces the availability of Fiscal Year (FY) 2012 funds for a cooperative agreement program. The purpose of this funding announcement is to support implementation of a viral hepatitis testing initiative to increase early identification of persons with HBV and HCV infections, with a focus on populations that are disproportionately affected by these infections, and to enhance linkage to care, treatment, and preventive services for persons with these infections.
The goals of this FOA are derived from the HHS Viral Hepatitis Action Plan (available at: HYPERLINK "http://www.hhs.gov/ash/initiatives/hepatitis"http://www.hhs.gov/ash/initiatives/hepatitis) and reflect the Healthy People 2020 Immunization and Infectious Diseases objectives.
CDC will support the provision of services that (1) enhance testing for HBV and HCV infections among persons for whom testing is indicated and (2) ensure that persons living with hepatitis B or hepatitis C are informed, appropriately counseled, and provided with linkage to care, treatment, and preventive services. Enhanced testing efforts should target populations disproportionately affected by chronic hepatitis B and hepatitis C, especially those that are medically underserved.
This FOA consists of two (2) categories: Category A - Early Identification and Linkage to Care for Foreign-born Persons with Hepatitis B; and Category B - Testing for HCV Infection and Enhancing Linkage to Medical Care for Persons with Hepatitis C. These components are described in detail below.
Category A - Early Identification and Linkage to Care for Foreign-born Persons with Hepatitis B
CDC anticipates awarding approximately 10 awards to grantees to work in collaboration with organizations/agencies targeting persons born in countries with intermediate (2%-7%) or high (>8%) hepatitis B prevalence. Actual award amounts will be competitive through scoring of applications. Only those applicants who meet the eligibility criteria will be considered.
Category B - Testing for HCV Infection and Enhancing Linkage to Medical Care for Persons with Hepatitis C
The program activities under Category B are divided into three parts:
Part 1 - HCV testing and linkage to care in settings that provide services to persons who inject drugs (PWID)
Part 2 - Hepatitis C services in community health centers (CHCs)
2a - HCV testing and linkage to care in CHCs
2b - Strengthening HCV care and treatment in CHCs
Part 3 - HCV testing and linkage to care in other settings
For each Part except Category B-Part 2b CDC anticipates awarding approximately 10 awards to grantees to increase HCV testing in the targeted settings and provide linkage to care, treatment, and preventive services for persons identified with HCV infection.
For Category B - Part 2b, CDC anticipates awarding approximately two (2) grantees to implement a telehealth knowledge network for sharing case presentations and facilitating consultations among CHCs, local health departments, and academic medical faculty with expertise in HCV care and treatment. Modeled after Project ECHO, the goals of the programs are to strengthen the capacity for HCV testing, care, and treatment within CHCs and other institutions in the network.
Applicants may apply for more than one category; however, separate applications are required. For Category B, separate applications are required for each part, with the exception of Part 2b, which can be combined with Part 2a. For applicants seeking funding for Category B - Part 2b, only those who apply for Category B - Part 2a will be considered.
Measurable Outcomes
Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the CDC Division of Viral Hepatitis (DVH), which reflect those outlined in the HHS Viral Hepatitis Action Plan:
Category A
an increase in the proportion of persons who are aware of their HBV infection status among populations born in countries with intermediate or high prevalence of HBV infection
an increase in the proportion of those persons testing positive for HBV infection (among those tested through the screening project) who receive prevention counseling and are linked to care treatment and prevention services.
Category B
Parts 1, 2a, and 3
an increase in the proportion of persons who are aware of their hepatitis C virus infection, especially persons at increased risk for transmission (e.g., PWID) and demographic populations with increased HCV prevalence and risk for morbidity and mortality (e.g., persons born from 1945 through 1965)
an increase in the proportion of those persons testing positive for hepatitis C (e.g., positive HCV RNA) who receive preventive services and are linked to care treatment and prevention services
Part 2b
an increase in the proportion of newly infected persons who are linked to best practice care and medical evaluation for treatment
an increase in the proportion of persons with chronic hepatitis C who receive antiviral therapy
|
|
| |
| |
|
|
|
